<DOC>
	<DOCNO>NCT01063101</DOCNO>
	<brief_summary>The purpose study investigate whether orally administer BAX 513 ( different dos administer 5 day ) affect hemostatic parameter healthy volunteer .</brief_summary>
	<brief_title>Phase 1 Dosing Study BAX 513 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Fucoidan</mesh_term>
	<criteria>Is &gt; = 18 &lt; 70 year old time screening Is able provide sign date informed consent Is healthy male female adult If female childbearing potential , subject demonstrate negative serum pregnancy test , agree employ adequate birth control measure ; ( e.g. , oral contraceptive , barrier method ) duration study If female receive hormone replacement therapy ( HRT ) , subject agree abstain HRT duration study Subject 's medical history physical exam normal Subject 's lab value complete blood count ( CBC ) clinical chemistry within normal range Is able comprehend comply aspects protocol sign informed consent If female , subject pregnant lactating time study enrollment Has participate another clinical study involve investigational product ( IP ) device within 30 day screen scheduled participate another clinical study involve IP device course study Has history drug allergy general hypersensitivity fucoidan contain products/foods seafood Medical and/or family history thrombophilic tendency , eg Protein C Sdeficiency , ATIII deficiency , FV Leiden mutation , Prothrombin 20210A mutation , lupus type inhibitor , antiphospholipid antibody Medical history clinical finding significant bleed disorder Medical history thrombotic event venous thromboembolism ( VTE ) , myocardial infarction ( MI ) , stroke transient ischemic attack ( TIA ) Any clinically relevant history disease , eg malabsorption disorder , malignancy Any clinically significant abnormal laboratory value abnormal ECG finding opinion investigator consider clinically relevant Seropositivity HBsAg , HCV , HIV1 HIV2 antibodies Symptoms clinically relevant illness within 3 week screen A history , suspect , drug alcohol abuse , subject test positive Drugs Abuse screen within 1 week dose Intake IP relate ( fucoidancontaining ) product within 1 week prior study enrollment Any plan surgical dental procedure course study Any recent surgery within 30 day enrollment Presence sign symptom consistent infection , fever , chill , nausea screen study Chronic regular use aspirin , ibuprofen , coumarin derivative , antiplatelet drug , within 1 week enrollment Use concomitant drug diclofenac [ paracetamol &gt; 2 g/day ] within 1 week first day study dose Plasmapheresis platelet donation within 3 week screen final visit Any medical condition may compromise ability give write informed consent comply study protocol Subject member team conduct study dependent relationship one study team member . Dependent relationship include close relative ( ie , child , partner/spouse , sibling , parent ) well employee investigator site personnel conduct study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>